Literature DB >> 17136992

The role of oxidative stress in chronic obstructive pulmonary disease.

Russell P Bowler1, Peter J Barnes, James D Crapo.   

Abstract

Tobacco smoke is the number one risk factor for chronic obstructive pulmonary disease (COPD) and contains a high concentration of oxidants. The lung has a high concentration of antioxidants and antioxidant enzymes; however, COPD patients show evidence of increased oxidative stress suggesting that endogenous antioxidants may be insufficient to prevent oxidative damage from cigarette smoke. The consequences of increased oxidative stress in the lung include increased transcription of inflammatory genes, increased protease activity, and increased mucus secretion. Oxidative stress is often associated with impaired skeletal muscle function and may be one of the causes of glucocorticoid resistance. While current pharmacologic approaches to the treatment of chronic obstructive pulmonary disease do not commonly include antioxidants, preclinical studies involving animal models suggest that antioxidant superoxide dismutase mimetics offer a potential new therapeutic approach to the prevention and treatment of chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17136992     DOI: 10.1081/copd-200027031

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  46 in total

1.  Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.

Authors:  Hye-Youn Cho; Bennett van Houten; Xuting Wang; Laura Miller-DeGraff; Jennifer Fostel; Wesley Gladwell; Ligon Perrow; Vijayalakshmi Panduri; Lester Kobzik; Masayuki Yamamoto; Douglas A Bell; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

2.  Ageing, smoking and oxidative stress.

Authors:  J F Donohue
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

Review 3.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

4.  Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Wesley Gladwell; Jacqui Marzec; Zackary R McCaw; Rachelle J Bienstock; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2014-11-12       Impact factor: 8.401

Review 5.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

6.  Correlation of Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema in C3H and C57Bl/6 Mice.

Authors:  Elias G Awji; Jean Clare Seagrave; Yohannes Tesfaigzi
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

Review 7.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12

8.  Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies.

Authors:  Gavin Pickett; Jeanclare Seagrave; Susan Boggs; Gregory Polzin; Patricia Richter; Yohannes Tesfaigzi
Journal:  Toxicol Sci       Date:  2009-12-15       Impact factor: 4.849

Review 9.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

Review 10.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.